253 related articles for article (PubMed ID: 16181131)
1. Positron Emission Tomography: applications in drug discovery and drug development.
Wang J; Maurer L
Curr Top Med Chem; 2005; 5(11):1053-75. PubMed ID: 16181131
[TBL] [Abstract][Full Text] [Related]
2. Microwave accelerated labeling methods in the synthesis of radioligands for positron emission tomography imaging.
Kallmerten AE; Alexander A; Wager KM; Jones GB
Curr Radiopharm; 2011 Oct; 4(4):343-54. PubMed ID: 22202157
[TBL] [Abstract][Full Text] [Related]
3. Small-animal positron emission tomography as a tool for neuropharmacology.
Lancelot S; Zimmer L
Trends Pharmacol Sci; 2010 Sep; 31(9):411-7. PubMed ID: 20599282
[TBL] [Abstract][Full Text] [Related]
4. Small animal PET in preclinical studies: opportunities and challenges.
Riemann B; Schäfers KP; Schober O; Schäfers M
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
[TBL] [Abstract][Full Text] [Related]
5. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
6. Small animal PET imaging.
Hutchins GD; Miller MA; Soon VC; Receveur T
ILAR J; 2008; 49(1):54-65. PubMed ID: 18172333
[TBL] [Abstract][Full Text] [Related]
7. Iodine-124: a promising positron emitter for organic PET chemistry.
Koehler L; Gagnon K; McQuarrie S; Wuest F
Molecules; 2010 Apr; 15(4):2686-718. PubMed ID: 20428073
[TBL] [Abstract][Full Text] [Related]
8. Target-specific delivery of peptide-based probes for PET imaging.
Chen K; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1005-22. PubMed ID: 20851156
[TBL] [Abstract][Full Text] [Related]
9. The use of imaging in preclinical drug development.
Vanderheyden JL
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):374-81. PubMed ID: 19834446
[TBL] [Abstract][Full Text] [Related]
10. [Application of pre-clinical PET imaging for drug development].
Tsukada H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
[TBL] [Abstract][Full Text] [Related]
11. Fundamentals of positron emission tomography and applications in preclinical drug development.
Cherry SR
J Clin Pharmacol; 2001 May; 41(5):482-91. PubMed ID: 11361044
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography for modeling pathophysiological processes in vivo.
Hendrikse NH; Luurtsema G; van der Veldt AA; Lubberink M
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):717-25. PubMed ID: 18729023
[TBL] [Abstract][Full Text] [Related]
13. Production of iodine-124 and its applications in nuclear medicine.
Braghirolli AM; Waissmann W; da Silva JB; dos Santos GR
Appl Radiat Isot; 2014 Aug; 90():138-48. PubMed ID: 24747530
[TBL] [Abstract][Full Text] [Related]
14. Positron emitting tracers in pre-clinical drug development.
Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography: a clinical and biological research tool].
Kotzki PO
J Soc Biol; 2004; 198(2):163-8. PubMed ID: 15368968
[TBL] [Abstract][Full Text] [Related]
16. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders.
Yoshinaga K; Chow BJ; dekemp RA; Thorn S; Ruddy TD; Davies RA; DaSilva JN; Beanlands R
Curr Pharm Des; 2005; 11(7):903-32. PubMed ID: 15777243
[TBL] [Abstract][Full Text] [Related]
17. Radiopharmaceuticals: molecular imaging using positron emission tomography.
Antoni G; Långström B
Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
[TBL] [Abstract][Full Text] [Related]
18. 89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?
Van Dongen GA; Huisman MC; Boellaard R; Harry Hendrikse N; Windhorst AD; Visser GW; Molthoff CF; Vugts DJ
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):18-38. PubMed ID: 25517081
[TBL] [Abstract][Full Text] [Related]
19. Imaging of myocardial fatty acid metabolism with PET.
Bergmann SR
J Nucl Cardiol; 2007; 14(3 Suppl):S118-24. PubMed ID: 17556179
[No Abstract] [Full Text] [Related]
20. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
Vallabhajosula S; Solnes L; Vallabhajosula B
Semin Nucl Med; 2011 Jul; 41(4):246-64. PubMed ID: 21624560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
